BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 15144956)

  • 1. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression.
    Chung CH; Parker JS; Karaca G; Wu J; Funkhouser WK; Moore D; Butterfoss D; Xiang D; Zanation A; Yin X; Shockley WW; Weissler MC; Dressler LG; Shores CG; Yarbrough WG; Perou CM
    Cancer Cell; 2004 May; 5(5):489-500. PubMed ID: 15144956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 3q oncogenes SEC62 and SOX2 on lymphatic metastasis and clinical outcome of head and neck squamous cell carcinomas.
    Bochen F; Adisurya H; Wemmert S; Lerner C; Greiner M; Zimmermann R; Hasenfus A; Wagner M; Smola S; Pfuhl T; Bozzato A; Al Kadah B; Schick B; Linxweiler M
    Oncotarget; 2017 Jan; 8(3):4922-4934. PubMed ID: 28002801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
    Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
    J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Classification of Lymph Node Metastases Subtypes Predict for Survival in Head and Neck Cancer.
    Huang L; David O; Cabay RJ; Valyi-Nagy K; Macias V; Zhong R; Wenig B; Feldman L; Weichselbaum R; Spiotto MT
    Clin Cancer Res; 2019 Mar; 25(6):1795-1808. PubMed ID: 30573692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Expression Comparison Between the Primary Tumor and its Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma: A Pilot Study.
    Karpathiou G; Stachowitz ML; Dumollard JM; Gavid M; Froudarakis M; Prades JM; Peoc'h M
    Cancer Genomics Proteomics; 2019; 16(3):155-161. PubMed ID: 31018946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three distinct genomic subtypes of head and neck squamous cell carcinoma associated with clinical outcomes.
    Lee DJ; Eun YG; Rho YS; Kim EH; Yim SY; Kang SH; Sohn BH; Kwon GH; Lee JS
    Oral Oncol; 2018 Oct; 85():44-51. PubMed ID: 30220319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
    Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
    Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subpath analysis of each subtype of head and neck cancer based on the regulatory relationship between miRNAs and biological pathways.
    An F; Zhang Z; Xia M; Xing L
    Oncol Rep; 2015 Oct; 34(4):1745-54. PubMed ID: 26239836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of microRNAs as markers for the detection of neck lymph node metastases in patients with head and neck squamous cell carcinoma.
    de Carvalho AC; Scapulatempo-Neto C; Maia DC; Evangelista AF; Morini MA; Carvalho AL; Vettore AL
    BMC Med; 2015 May; 13():108. PubMed ID: 25956054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of SERPINB13 expression in head and neck squamous cell carcinomas associates with poor clinical outcome.
    de Koning PJ; Bovenschen N; Leusink FK; Broekhuizen R; Quadir R; van Gemert JT; Hordijk GJ; Chang WS; van der Tweel I; Tilanus MG; Kummer JA
    Int J Cancer; 2009 Oct; 125(7):1542-50. PubMed ID: 19569240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.
    Liu CJ; Liu TY; Kuo LT; Cheng HW; Chu TH; Chang KW; Lin SC
    J Pathol; 2008 Mar; 214(4):489-97. PubMed ID: 18213732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of gene expression between metastatic derivatives and their poorly metastatic parental cells implicates crucial tumor-environment interaction in metastasis of head and neck squamous cell carcinoma.
    Chen Z; Zhang K; Zhang X; Yuan XH; Yuan Z; Jin L; Xiong M
    Clin Exp Metastasis; 2003; 20(4):335-42. PubMed ID: 12856721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance of head and neck tumor gene expression profiles upon lymph node metastasis.
    Roepman P; de Jager A; Groot Koerkamp MJ; Kummer JA; Slootweg PJ; Holstege FC
    Cancer Res; 2006 Dec; 66(23):11110-4. PubMed ID: 17145852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma.
    Chung CH; Parker JS; Ely K; Carter J; Yi Y; Murphy BA; Ang KK; El-Naggar AK; Zanation AM; Cmelak AJ; Levy S; Slebos RJ; Yarbrough WG
    Cancer Res; 2006 Aug; 66(16):8210-8. PubMed ID: 16912200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboxyl-Terminal Modulator Protein Positively Acts as an Oncogenic Driver in Head and Neck Squamous Cell Carcinoma via Regulating Akt phosphorylation.
    Chang JW; Jung SN; Kim JH; Shim GA; Park HS; Liu L; Kim JM; Park J; Koo BS
    Sci Rep; 2016 Jun; 6():28503. PubMed ID: 27328758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
    Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
    Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.
    Li G; Ren S; Su Z; Liu C; Deng T; Huang D; Tian Y; Qiu Y; Liu Y
    Tumour Biol; 2015 May; 36(5):3949-56. PubMed ID: 25578493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression analysis of head and neck squamous cell carcinoma survival and recurrence.
    Zhi X; Lamperska K; Golusinski P; Schork NJ; Luczewski L; Kolenda T; Golusinski W; Masternak MM
    Oncotarget; 2015 Jan; 6(1):547-55. PubMed ID: 25575813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular classification of head and neck squamous cell carcinoma using cDNA microarrays.
    Belbin TJ; Singh B; Barber I; Socci N; Wenig B; Smith R; Prystowsky MB; Childs G
    Cancer Res; 2002 Feb; 62(4):1184-90. PubMed ID: 11861402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional microarray analysis suggests repressed cell-cell signaling and cell survival-related modules inhibit progression of head and neck squamous cell carcinoma.
    Coló AE; Simoes AC; Carvalho AL; Melo CM; Fahham L; Kowalski LP; Soares FA; Neves EJ; Reis LF; Carvalho AF
    BMC Med Genomics; 2011 Apr; 4():33. PubMed ID: 21489260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.